Arcosa (ACA) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
21 Dec, 2025Executive summary
Achieved double-digit revenue and Adjusted EBITDA growth in Q4 and full year 2024, with record free cash flow and significant margin expansion, driven by organic growth and transformative acquisitions (Stavola and Ameron).
Portfolio optimization included divestitures of non-core assets, notably the steel components business, reducing complexity and cyclicality.
Ended 2024 with Net Debt to Adjusted EBITDA of 2.9x, down from 3.4x in Q3, and fully repaid revolver borrowings.
Financial highlights
FY 2024 revenues rose 11% to $2.57B (excluding divested steel components), with Adjusted EBITDA up 22% to $447M and margin expansion to 17.7%.
Q4 2024 revenues increased 14% to $666M; Adjusted EBITDA surged 52% to $128M, margin reached 19.3%.
Q4 free cash flow $199.2M; full year free cash flow $330.6M, up from $94.1M last year.
Q4 operating cash flow $248M, up from $62M prior year.
FY 2024 net income $147.9M (adjusted: $158.1M); Q4 adjusted net income $22.6M.
Outlook and guidance
2025 revenue guidance: $2.8–$3.0B; Adjusted EBITDA: $545–$595M, implying 30% growth at midpoint and margin expansion to 19.7%.
CapEx expected to decrease to $145–$165M in 2025, focusing on maintenance and completion of growth projects.
Growth expected to be 60% inorganic (acquisitions) and 40% organic.
Effective tax rate expected at 19–20% for 2025.
Anticipates additional deleveraging in the second half of 2025.
Latest events from Arcosa
- Record 2025 growth, barge divestiture, and strong 2026 EBITDA outlook with margin expansion.ACA
Q4 202527 Feb 2026 - Record Q2 results, $1.2B Stavola deal, and portfolio actions drive growth and margin gains.ACA
Q2 20242 Feb 2026 - Transformational acquisition boosts aggregates to 65% of EBITDA, fueling growth and margin expansion.ACA
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Q3 2024 Adjusted EBITDA rose 39% with margin gains and raised guidance after major portfolio moves.ACA
Q3 202417 Jan 2026 - Strong financials, board independence, and sustainability drive 2025 proxy proposals.ACA
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, approve executive pay, and ratify auditor, all board-backed.ACA
Proxy Filing1 Dec 2025 - Record Q2 2025 revenue and margin growth, with robust outlook and strong segment performance.ACA
Q2 202523 Nov 2025 - Q1 2025 Adjusted EBITDA up 26% with margin gains; net income down on higher interest.ACA
Q1 202518 Nov 2025 - Stavola acquisition boosts aggregates growth as portfolio shifts toward higher-margin, resilient markets.ACA
Sidoti's Small-Cap Virtual Conference11 Nov 2025